Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 1 (January)

1. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.
   Qual Life Res, 16(1): 89-100. [Abstract] [Full-text]
2. (11)C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer Wachter S, Tomek S, Kurtaran A, Wachter-Gerstner N, Djavan B, Becherer A, Mitterhauser M, Dobrozemsky G, Li S, Pötter R, Dudczak R, Kletter K, Departments of Nuclear Medicine, Radiotherapy, and Urology and Clinical Division of Oncology, Department of Medicine I, Hospital Pharmacy of the General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.
   Urol Oncol, 25(1): 90. [Abstract] [Full-text]
3. Economics of new oncology drug development.
   J Clin Oncol, 25(2): 209-16. [Abstract] [Full-text]
4. Interpreting the economic literature in oncology.
   J Clin Oncol, 25(2): 196-202. [Abstract] [Full-text]
5. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I.
   Pediatr Blood Cancer, 48(3): 364-9. [Abstract] [Full-text]
6. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
   Pediatr Blood Cancer, 48(3): 285-91. [Abstract] [Full-text]
7. Computer-enhanced robotic surgery in gynecologic oncology.
   Surg Endosc, 21(2): 244-6. [Abstract] [Full-text]
8. Twice-daily pain monitoring as standard clinical practice for inpatients at a medical oncology unit: a descriptive study.
   Ann Oncol, 18(1): 158-62. [Abstract] [Full-text]
9. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group.
   Gynecol Oncol, 104(1): 114-119. [Abstract] [Full-text]
10. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.
    Eur J Cancer, 43(1): 14-34. [Abstract] [Full-text]
11. Birth characteristics, maternal reproductive history, and the risk of infant leukemia: a report from the Children's Oncology Group.
    Cancer Epidemiol Biomarkers Prev, 16(1): 128-34. [Abstract] [Full-text]
12. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Cancer, 109(2): 274-81. [Abstract] [Full-text]
13. Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21.
    Oncologist, 12(1): 99-106. [Abstract] [Full-text]
14. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial.
    Eur J Cancer Care (Engl), 16(1): 67-73. [Abstract] [Full-text]
15. Therapeutic patient education in oncology: pedagogical notions for women's health and prevention.
    Eur J Cancer Care (Engl), 16(1): 9-11. [Abstract] [Full-text]
16. Take care! The evaluation of a team-based burnout intervention program for oncology care providers.
    J Appl Psychol, 92(1): 213-27. [Abstract] [Full-text]
17. A Strategy for Controlling Potential Interactions Between Natural Health Products and Chemotherapy: A Review in Pediatric Oncology.
    J Pediatr Hematol Oncol, 29(1): 32-47. [Abstract] [Full-text]
18. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    J Clin Oncol, 25(3): 313-8. [Abstract] [Full-text]
19. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Biochem Soc Trans, 35: 61-7. [Abstract] [Full-text]
20. Portal imaging practice patterns of children's oncology group institutions: Dosimetric assessment and recommendations for minimizing unnecessary exposure.
    Int J Radiat Oncol Biol Phys, 67(2): 594-600. [Abstract] [Full-text]
21. Analysis of progression-free survival in oncology trials: some common statistical issues.
    Pharm Stat. [Abstract] [Full-text]
22. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
    Biol Blood Marrow Transplant, 13(2): 218-27. [Abstract] [Full-text]
23. The role of PDGF in radiation oncology.
    Radiat Oncol, 2: 5. [Abstract] [Full-text]
24. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.
    Breast Cancer Res Treat, 101(3): 349-53. [Abstract] [Full-text]
25. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Blood, 109(3): 926-35. [Abstract] [Full-text]
26. Compressing drug development timelines in oncology using phase '0' trials.
    Nat Rev Cancer, 7(2): 131-9. [Abstract] [Full-text]
27. European Society for Medical Oncology 2006: meeting highlights on targeted therapies Istanbul, Turkey, 29 September-3 October 2006.
    Expert Opin Biol Ther, 7(2): 269-78. [Abstract] [Full-text]
28. Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire.
    Eur J Cancer, 43(2): 323-330. [Abstract] [Full-text]
29. Cancer stem cells and "stemness" genes in neuro-oncology.
    Neurobiol Dis, 25(2): 217-29. [Abstract] [Full-text]
30. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Clin Cancer Res, 13(2): 451-7. [Abstract] [Full-text]
31. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
32. Pharmacogenetics and oncology treatment for breast cancer.
    Expert Opin Pharmacother, 8(2): 119-27. [Abstract] [Full-text]
33. Ethics in oncology: consulting for the investment industry.
    J Clin Oncol, 25(4): 444-6. [Abstract] [Full-text]
34. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 25(4): 437-43. [Abstract] [Full-text]
35. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.
    J Clin Oncol, 25(4): 418-23. [Abstract] [Full-text]
36. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
    J Clin Oncol, 25(4): 362-9. [Abstract] [Full-text]
37. Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
    J Clin Oncol, 25(4): 356-61. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.